Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-004308
Filing Date
2017-02-07
Accepted
2017-02-07 16:38:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 25515
  Complete submission text file 0000000000-17-004308.txt   35943
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filed for) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances